Predictive Value of Serum FOXM1 and CCR5 Levels in AECOPD Patients with Lung Function and Prognosis
10.3969/j.issn.1671-7414.2024.03.030
- VernacularTitle:AECOPD患者血清FOXM1和CCR5水平与肺功能及预后的预测价值研究
- Author:
Mingmin HUANG
1
;
Dan LI
;
Huang LI
;
Shoushuo FU
;
Chunlong LIN
Author Information
1. 岳阳市人民医院呼吸内科,湖南岳阳 414022
- Keywords:
acute exacerbation of chronic obstructive pulmonary disease;
lung function;
forkhead box M1;
CC chemokine receptor 5
- From:
Journal of Modern Laboratory Medicine
2024;39(3):176-182
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the evaluation value of forkhead box M1(FOXM1)and CC chemokine receptor 5(CCR5)on lung function and prognosis in elderly patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods A total of 128 AECOPD patients admitted to Yueyang People's Hospital from January 2022 to January 2023 were collected as the acute exacerbation group,135 stable COPD patients admitted at the same time were regarded as the stable phase group,and 120 health examination volunteers of similar age and gender were regarded as the control group.Enzyme-linked immunosorbent assay(ELISA)was applied to detect the expression levels of FOXM1 and CCR5 in serum,and the vital capacity meter was applied to measure pulmonary function.Pearson method was applied to analyze the correlation between serum FOXM1,CCR5 and lung function indicators in AECOPD patients.Multivariate logistic regression analysis was applied to screen prognostic factors for AECOPD patients.The evaluation value of FOXM1 and CCR5 levels in evaluating poor prognosis of AECOPD patients was analyzed by receiver operating characteristic(ROC)curve.Results In the serum of patients in the AE COPD group and stable stage group,the levels of CCR5(49.36±12.31 ng/ml,34.25±8.87 ng/ml)and FOXM1(40.21±10.74 pg/ml,23.38±5.77 pg/ml)were significantly higher than those in the control group(14.55±4.58 ng/ml,15.06±3.55 pg/ml),while FEV1(1.15±0.13 L,1.67±0.19 L),FVC(2.93±0.30 L,3.28±0.36 L)and FEV1/FVC(39.25％±3.97％,50.91％±5.01％)were lower than those in the control group(1.95±0.26 L,3.57±0.44 L,54.62％±5.20％),with significant differences(F=11 1.034～641.907,all P＜0.05).The levels of serum FOXM1 and CCR5 were gradually increased with the aggravation of lung function grading,while the levels of lung function indicators FEV1 and FVC were gradually decreased with the aggravation of lung function grading,and the differences were statistically significant(F=31.27,49.37;42.72,29.48,all P＜0.05).The serum levels of FOXM1 and CCR5 were negatively correlated with FEV1,FVC and FEV1/FVC(r=-0.639～-0.479,all P＜0.05).Logistic regression analysis found that CCR5[OR(95％CI):3.380(1.944～5.876)],FOXM1[OR(95％CI):5.711(3.175～10.273)],APACHE Ⅱ score[OR(95％CI):2.132(1.243～3.660)],and lung function grading[OR(95CI):2.017(1.007～4.037)]were all risk factors for poor prognosis(all P＜0.05),while FEV1[OR(95％CI):0.649(0.441～0.955)]and FVC[OR(95％CI):0.120(0.073～0.198)]were protective factors for poor prognosis(all P＜0.05).ROC curve results showed that the areas under the curve(AUC)of serum FOXM1 and CCR5 levels in predicting poor prognosis in AECOPD patients were 0.821 and 0.831,respectively.The AUC predicted by the combination of the two was 0.895,which was higher than that detected by a single indicator(Z=2.800,2.654,all P＜0.05).Conclusion FOXM1 and CCR5 were both high levels in the serum of AECOPD patients.Early detection of them can serve as serum markers for evaluating lung function and poor prognosis in AECOPD patients.
